Right Smile - 500 Beiträge pro Seite
eröffnet am 18.11.11 16:52:27 von
neuester Beitrag 10.01.14 09:03:20 von
neuester Beitrag 10.01.14 09:03:20 von
Beiträge: 56
ID: 1.170.467
ID: 1.170.467
Aufrufe heute: 0
Gesamt: 1.874
Gesamt: 1.874
Aktive User: 0
Top-Diskussionen
| Titel | letzter Beitrag | Aufrufe |
|---|---|---|
| vor 49 Minuten | 11045 | |
| vor 1 Stunde | 2668 | |
| vor 50 Minuten | 2385 | |
| vor 48 Minuten | 1701 | |
| vor 1 Stunde | 1092 | |
| vor 48 Minuten | 890 | |
| vor 1 Stunde | 845 | |
| heute 09:46 | 655 |
Meistdiskutierte Wertpapiere
| Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
|---|---|---|---|---|---|---|---|
| 1. | 1. | 18.187,39 | +0,14 | 224 | |||
| 2. | 2. | 150,90 | +11,53 | 195 | |||
| 3. | 8. | 8,9350 | -38,42 | 135 | |||
| 4. | 5. | 0,0313 | +95,63 | 45 | |||
| 5. | 3. | 0,1995 | +4,45 | 43 | |||
| 6. | 9. | 738,90 | +3,76 | 41 | |||
| 7. | 7. | 4,6540 | -2,02 | 34 | |||
| 8. | 4. | 2.317,20 | -0,21 | 33 |
Feedback
AS = 2.5 bil
OS = 1,585,657,296
Float = 1,068,836,336
Merger in aussicht
Achtung OTC nur für Gamer
0.0004-0.0005
OS = 1,585,657,296
Float = 1,068,836,336
Merger in aussicht
Achtung OTC nur für Gamer
0.0004-0.0005
immer noch bei 0.0005
denkt daran schrott aktie nur mit spielgeld kaufen
denkt daran schrott aktie nur mit spielgeld kaufen
vol.22,000,000
0.0005-0.0006
kann auch ein scam sein
TOFS is handling the R/M for R!GH now DEVTEK. Rumor has it and I say rumor, there might be another company involved in another merger in the not to distant future. During the period of R/M there is a gag period and no information can be released to influence pps. Matt put out a pr about the settlement of a lawsuit that was in favor of R!GH, thuse allowing R/M to be completed. I truly believe someone called the PINKY POLICE and reported them resulting in a CE. OCTpink is an unoffical regulatory co that relies on fees and penalty fees to function financially. I also believe that was information was crutial to all stockholders no matter what the situation was and should not have resulted in any kind of penalty. Financial obligations to R!GH have been handled by TOFS, TOFS will be compensated for the merger and TOFS, soon to be BARON will also have a new client. R!GH has submitted the necessary documents and attorney letter to gain pink status and merger will go through. No diluton needed. PPS goes up on both. Business plan continues for Baron and when succesful, no telling where this stock will go. I don't knowwhen, because this is a major Holiday and most employees will take asmany sick days as possible, to ave the whole week off, so it might not be until nextweek that all the goodies get posted. Hangon an get ready for a ride!!! Happy Thankgiving There is some excellant DD on this board, check it out and R!GH, it will explain the story, warning though, eat the fish and throw out the bones.
TOFS is handling the R/M for R!GH now DEVTEK. Rumor has it and I say rumor, there might be another company involved in another merger in the not to distant future. During the period of R/M there is a gag period and no information can be released to influence pps. Matt put out a pr about the settlement of a lawsuit that was in favor of R!GH, thuse allowing R/M to be completed. I truly believe someone called the PINKY POLICE and reported them resulting in a CE. OCTpink is an unoffical regulatory co that relies on fees and penalty fees to function financially. I also believe that was information was crutial to all stockholders no matter what the situation was and should not have resulted in any kind of penalty. Financial obligations to R!GH have been handled by TOFS, TOFS will be compensated for the merger and TOFS, soon to be BARON will also have a new client. R!GH has submitted the necessary documents and attorney letter to gain pink status and merger will go through. No diluton needed. PPS goes up on both. Business plan continues for Baron and when succesful, no telling where this stock will go. I don't knowwhen, because this is a major Holiday and most employees will take asmany sick days as possible, to ave the whole week off, so it might not be until nextweek that all the goodies get posted. Hangon an get ready for a ride!!! Happy Thankgiving There is some excellant DD on this board, check it out and R!GH, it will explain the story, warning though, eat the fish and throw out the bones.
Trading Spotlight
RIGH (OTC)
RIGH
hat wieder pink status das gibt es selten
momo play in aussicht!
hat wieder pink status das gibt es selten
momo play in aussicht!
RightSmile Restored to Current Information as the Company Rolls Towards Completion of a Reverse Merger
Nov 30, 2011 8:30:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Nov. 30, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH:PK) is pleased to announce the Company has been fully restored to Current Information on Otcmarkets.com.
RightSmile recently announced its plans on completing a Reverse Merger once the Company was restored to Current Information. During this time, the Company has been completing other tasks needed to complete the transaction and should be in a position to close within the next few weeks. Complete details pertaining to the executed LOI will be released within the next few days as the Company completes the remaining open items.
The Company merging into RightSmile is not DevTek as this is an existing entity owned by RightSmile. The merging company is a private entity located on the West Coast servicing a multi billion dollar market just in its home state. This industry has been featured on CNBC a few times and has several publications dedicated to covering the market place. The industry has had over 13 million online searches for the main keyword and 600,000 in Google just in April of 2009 alone, since in 2.5 years the popularity of the terms has risen 712% and 3000% representing a 12% month over month growth rate searching this market.
Upon completion of the reverse merger DevTek will be spun out and a brand new company and management team will takeover.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Randy Schneider
561-404-4895
Nov 30, 2011 8:30:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Nov. 30, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH:PK) is pleased to announce the Company has been fully restored to Current Information on Otcmarkets.com.
RightSmile recently announced its plans on completing a Reverse Merger once the Company was restored to Current Information. During this time, the Company has been completing other tasks needed to complete the transaction and should be in a position to close within the next few weeks. Complete details pertaining to the executed LOI will be released within the next few days as the Company completes the remaining open items.
The Company merging into RightSmile is not DevTek as this is an existing entity owned by RightSmile. The merging company is a private entity located on the West Coast servicing a multi billion dollar market just in its home state. This industry has been featured on CNBC a few times and has several publications dedicated to covering the market place. The industry has had over 13 million online searches for the main keyword and 600,000 in Google just in April of 2009 alone, since in 2.5 years the popularity of the terms has risen 712% and 3000% representing a 12% month over month growth rate searching this market.
Upon completion of the reverse merger DevTek will be spun out and a brand new company and management team will takeover.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Randy Schneider
561-404-4895
heute schluss bei 0.0006 vol.57,000,000
0.0006-0.0007 vol.67,000,000
0.0007 vol.148,000,000
0.0007-0.0008 vol.192,000,000
schluss bei 0.0008
vol.85,000,000
vol.85,000,000
nächste woche merger details? es wird spannend
RightSmile Rolls On With Its Pending Reverse Merger in the Cannibis Market
Dec 5, 2011 11:08:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Dec. 5, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH:PK) has received a lot of emails and phone calls regarding the entity being merged in. The company is located in California and is in the lucrative Cannabis industry.
This industry as reported by CNBC and National Geographic is the latest gold rush to hit the market place. Cannabis has captured the eye of Wall Street and everyone else looking for the next big thing. The market size in California alone has been reported to be as large as $14 billion dollars, not including the other 15 States that have legalized medical marijuana.
The new entity has nothing to do with DevTek and no one from the past has any affiliation with the new entity except 247MGI, Inc (OTC:TOFS) who has assisted the Company in completing this transaction. TOFS is a large debt holder in RIGH and is expected to enter into a long term deal with the new company post merger.
On Wednesday, a full announcement containing the name and information of the new company shall be released.
Dec 5, 2011 11:08:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Dec. 5, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH:PK) has received a lot of emails and phone calls regarding the entity being merged in. The company is located in California and is in the lucrative Cannabis industry.
This industry as reported by CNBC and National Geographic is the latest gold rush to hit the market place. Cannabis has captured the eye of Wall Street and everyone else looking for the next big thing. The market size in California alone has been reported to be as large as $14 billion dollars, not including the other 15 States that have legalized medical marijuana.
The new entity has nothing to do with DevTek and no one from the past has any affiliation with the new entity except 247MGI, Inc (OTC:TOFS) who has assisted the Company in completing this transaction. TOFS is a large debt holder in RIGH and is expected to enter into a long term deal with the new company post merger.
On Wednesday, a full announcement containing the name and information of the new company shall be released.
heute schluss bei 5 vol.145,000,000
sell of NEWS
denke nicht das es so ist weil es waren mehr käufer am markt,kann sein das die MM's das ding drückten um es aufzuladen für die NEWS am mittwoch die relevant ist.es bleibt spannend.
die andere variante dilution,alles ist möglich
sell of NEWS
denke nicht das es so ist weil es waren mehr käufer am markt,kann sein das die MM's das ding drückten um es aufzuladen für die NEWS am mittwoch die relevant ist.es bleibt spannend.
die andere variante dilution,alles ist möglich
Buys 61,740,349
Sells 47,822,743
Sells 47,822,743
Alternative Healing Goes High Tech: RightSmile and BG Medical Technologies Merge to Further Transform the Medical Cannabis Market
Dec 7, 2011 8:39:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Dec. 7, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC: RIGH.PK) is pleased to announce the details of its pending Reverse Merger, to be completed later this month, … [RM info] … with BG Medical Technologies, Inc., an industry leader in medical cannabis laboratory analysis, and developer of popular medical cannabis website www.BudGenius.com.
BudGenius.com currently services the medical cannabis market utilizing a proprietary software engine that assists in predicting the medicinal effects of cannabis strains through a combination of laboratory chromatography analysis and patient response data received through its social media portal. Research results are displayed upon on the BudGenius.com website, and also within participating cannabis dispensaries, to assist patients in selecting cannabis strains that address their intended medical needs.
"We find this merger of science and social media to be quite remarkable," stated CEO Angel Stanz. "Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson's disease, Alzheimer's, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies."
BudGenius entered the medical cannabis industry as a pioneer in medical marijuana testing by providing the first online laboratory-tested strain database for patient and medical professionals. BudGenius continues to deliver industry-leading services, and maintains the largest online photographic database of tested cannabis medicine worldwide, obtained from over 230 independent sources within California. BudGenius.com is the most visited online portal for cannabis testing services.
"This [merger with RightSmile] provides BudGenius and BG Medical Technologies the resources to develop new levels of patient care for alternative medical treatments," explains Mr. Stanz. "In 2012, BG Medical will continue our innovations by introducing support tools for medical care professionals, additional business tools for dispensaries, and interactive educational media content for patients. These features will be HIPAA-compliant, where applicable, and mobile app-enabled for patient convenience. "
The breakthrough services BudGenius currently provides are powered by the combination of science, social media, and software development. Every cannabis plant represents a unique set of therapeutic characteristics based upon its genetics and growing environment. Each harvest is analyzed to determine its chemical composition and its safety for consumption. Patients receiving BudGenius tested medicine report on the efficacy of the experienced effects by utilizing the BudGenius.com social portal. These experiences are then mapped to the unique chemical ratios comprising the patient's cannabis strain. This produces a loosely controlled scientific trial of thousands of patients, all contributing data in real-time to BG Medical's server cloud. This information is then processed to extrapolate an ailment rating system for newly analyzed strains.
"We find this merger of science and social media to be quite remarkable," continues Mr. Stanz. "Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson's disease, Alzheimer's, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies."
BudGenius derives its revenue through cannabis analysis services. New growth will include targeted advertising services, physician support systems, medicinal administration solutions, and software licensing. Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this [$x million market] demand through territory expansion and appropriate acquisitions.
About BG Medical Technologies, Inc.
BG Medical Technologies is a life sciences solution developer for alternative medical treatments headquartered in California. BG Medical Technologies owns and operates BudGenius.com, a social web laboratory providing medical cannabis safety and treatment analysis.
Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this demand through territory expansion and its cloud-based architecture for supporting multiple licensed laboratory locations. New areas of growth include Internet advertising revenue, physician support software, and diagnostic support tools.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Randy Schneider
561-404-4895
SOURCE RightSmile, Inc.
Dec 7, 2011 8:39:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Dec. 7, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC: RIGH.PK) is pleased to announce the details of its pending Reverse Merger, to be completed later this month, … [RM info] … with BG Medical Technologies, Inc., an industry leader in medical cannabis laboratory analysis, and developer of popular medical cannabis website www.BudGenius.com.
BudGenius.com currently services the medical cannabis market utilizing a proprietary software engine that assists in predicting the medicinal effects of cannabis strains through a combination of laboratory chromatography analysis and patient response data received through its social media portal. Research results are displayed upon on the BudGenius.com website, and also within participating cannabis dispensaries, to assist patients in selecting cannabis strains that address their intended medical needs.
"We find this merger of science and social media to be quite remarkable," stated CEO Angel Stanz. "Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson's disease, Alzheimer's, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies."
BudGenius entered the medical cannabis industry as a pioneer in medical marijuana testing by providing the first online laboratory-tested strain database for patient and medical professionals. BudGenius continues to deliver industry-leading services, and maintains the largest online photographic database of tested cannabis medicine worldwide, obtained from over 230 independent sources within California. BudGenius.com is the most visited online portal for cannabis testing services.
"This [merger with RightSmile] provides BudGenius and BG Medical Technologies the resources to develop new levels of patient care for alternative medical treatments," explains Mr. Stanz. "In 2012, BG Medical will continue our innovations by introducing support tools for medical care professionals, additional business tools for dispensaries, and interactive educational media content for patients. These features will be HIPAA-compliant, where applicable, and mobile app-enabled for patient convenience. "
The breakthrough services BudGenius currently provides are powered by the combination of science, social media, and software development. Every cannabis plant represents a unique set of therapeutic characteristics based upon its genetics and growing environment. Each harvest is analyzed to determine its chemical composition and its safety for consumption. Patients receiving BudGenius tested medicine report on the efficacy of the experienced effects by utilizing the BudGenius.com social portal. These experiences are then mapped to the unique chemical ratios comprising the patient's cannabis strain. This produces a loosely controlled scientific trial of thousands of patients, all contributing data in real-time to BG Medical's server cloud. This information is then processed to extrapolate an ailment rating system for newly analyzed strains.
"We find this merger of science and social media to be quite remarkable," continues Mr. Stanz. "Today we are producing first looks into cannabinoid ratio effects, which has been facilitated by laboratory work and social media. In the near future we expect to correlate these findings to better support doctors in recommending specific strains for treatments in cancer, Parkinson's disease, Alzheimer's, and more. Cannabis is just the beginning. We strongly believe this matching of science and social media is a blueprint for improving the efficacy of many alternative therapies."
BudGenius derives its revenue through cannabis analysis services. New growth will include targeted advertising services, physician support systems, medicinal administration solutions, and software licensing. Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this [$x million market] demand through territory expansion and appropriate acquisitions.
About BG Medical Technologies, Inc.
BG Medical Technologies is a life sciences solution developer for alternative medical treatments headquartered in California. BG Medical Technologies owns and operates BudGenius.com, a social web laboratory providing medical cannabis safety and treatment analysis.
Legislation supporting medical cannabis continues to be introduced nationwide often including regulations mandating cannabis analysis services for patient safety concerns. BudGenius is meeting this demand through territory expansion and its cloud-based architecture for supporting multiple licensed laboratory locations. New areas of growth include Internet advertising revenue, physician support software, and diagnostic support tools.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance, or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Randy Schneider
561-404-4895
SOURCE RightSmile, Inc.
BG Medical Executive Bios
John W. Huelskamp, President/CEO
John W. Huelskamp has over 25 years of executive management and sales and marketing experience in the Medical Industry. Prior to founding BG Medical, he served as President of MedChannel’s Distribution and General Surgery Group. In this capacity he positioned three medical device companies for successful commercialization in the United States. Revenues for all three companies are at a run rate of $25 million+ for the third year since introduction, and all are positioned for Acquisition or IPO.
John W. Huelskamp, President/CEO
John W. Huelskamp has over 25 years of executive management and sales and marketing experience in the Medical Industry. Prior to founding BG Medical, he served as President of MedChannel’s Distribution and General Surgery Group. In this capacity he positioned three medical device companies for successful commercialization in the United States. Revenues for all three companies are at a run rate of $25 million+ for the third year since introduction, and all are positioned for Acquisition or IPO.
Just recieved this from Angel, quick response, positive outlook. GO RIGH You might want to sticky this
Dennis,
The announcement today is valid. We are excited to be moving forward with RIGH to place BG Med Tech and BudGenius.com as the first publicly traded medical cannabis laboratory. On behalf of our team, our kindest thanks for your support.
The merger is expected to be completed shortly as per today's announcement. We are committed to building value for our shareholders. Technology milestones and subsequent results will be announced in the upcoming weeks. We have a busy 1Q planned for 2012. As we complete the transition, I recommend that you stay tuned to the BudGenius.com website, and the newswires, for the most up to date information.
Warm Regards,
--Angel Stanz
CEO, President
BudGenius.com
angel@budgenius.com
office: (855) 723-3283
http://www.budgenius.com
Dennis,
The announcement today is valid. We are excited to be moving forward with RIGH to place BG Med Tech and BudGenius.com as the first publicly traded medical cannabis laboratory. On behalf of our team, our kindest thanks for your support.
The merger is expected to be completed shortly as per today's announcement. We are committed to building value for our shareholders. Technology milestones and subsequent results will be announced in the upcoming weeks. We have a busy 1Q planned for 2012. As we complete the transition, I recommend that you stay tuned to the BudGenius.com website, and the newswires, for the most up to date information.
Warm Regards,
--Angel Stanz
CEO, President
BudGenius.com
angel@budgenius.com
office: (855) 723-3283
http://www.budgenius.com
gestern schluss bei 0.0004
die zocker sind raus und wichtig gewinne mitnehmen und einsatz laufen lassen,wenn keine dilution dahinter steckt könnte was aus dieser schrottbude werden,die basher haben gestern gut gearbeitet.
die zocker sind raus und wichtig gewinne mitnehmen und einsatz laufen lassen,wenn keine dilution dahinter steckt könnte was aus dieser schrottbude werden,die basher haben gestern gut gearbeitet.
0.0002 neuer anlauf zum kiff merger
zweiter zock? schrottbude mal 2 geil
zweiter zock? schrottbude mal 2 geil
RightSmile to Hold Investor Conference Call
Dec 13, 2011 4:22:00 PM
Close Ad
Email story | Discuss on ZenoBank | View more ads
FT. LAUDERDALE, Fla., Dec. 13, 2011 /PRNewswire/ -- RightSmile (OTC:RIGH: PK) plans to hold a joint Investor Conference call on Wednesday, December 14, 2011 starting at 8:30 AM ET with Randy Schneider and Angel Stanz to field questions and address concerns regarding RIGH and Bud Genius.
The Call in information is:
Conference dial-in number: (209) 647-1600
Access code: 154229#
During the conference we ask each caller to limit their questions to one each, allowing as many callers as possible to participate. We also request that listeners pay attention to questions asked so we do not waste time answering the same questions more then once.
"The call will last at least 30 minutes and we look forward to clearing up a lot of confusion within the market place," stated Randy Schneider.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Dec 13, 2011 4:22:00 PM
Close Ad
Email story | Discuss on ZenoBank | View more ads
FT. LAUDERDALE, Fla., Dec. 13, 2011 /PRNewswire/ -- RightSmile (OTC:RIGH: PK) plans to hold a joint Investor Conference call on Wednesday, December 14, 2011 starting at 8:30 AM ET with Randy Schneider and Angel Stanz to field questions and address concerns regarding RIGH and Bud Genius.
The Call in information is:
Conference dial-in number: (209) 647-1600
Access code: 154229#
During the conference we ask each caller to limit their questions to one each, allowing as many callers as possible to participate. We also request that listeners pay attention to questions asked so we do not waste time answering the same questions more then once.
"The call will last at least 30 minutes and we look forward to clearing up a lot of confusion within the market place," stated Randy Schneider.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
GH Introduces Incoming CEO Angel Stanz and BudGenius
Dec 14, 2011 9:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
FT. LAUDERDALE, Fla., Dec. 14, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH: PK)
Angel Stanz, CEO of BG Medical Technologies, Inc., represents an accomplished history having held top positions inside several influential technology development firms. During the dot com era, Mr. Stanz served as Senior Research & Development Engineer for CAIS Software Solutions (previously ATCOM/INFO). CAIS became the innovation leader that spearheaded public Internet access solutions, and is responsible for introducing the Internet connector technologies that business travelers enjoy in hotels and cafes across the world daily. Angel worked directly with hardware manufacturers to introduce new protocols to Cisco, 3Com, Cabletron, and Tut Systems microchips that have now become standard features in public access deployments globally. In addition to overseeing high profile installations for Hilton and Marriott brands, he also oversaw the first home-based wifi installations to premier residential properties. A strong focus was placed upon delivering voice/video/data across existing telephone infrastructures utilizing prototype and emergent DSL technologies. Angel also assisted in delivering premier solutions for digitally delivered video content to hotel televisions, a system that has now replaced older VCR decks previously used to queue in-room entertainment. CAIS received investments from Microsoft, KKR ("Kravis, Kohlberg, & Roberts"), and culminated with a successful acquisition of CAIS Software Solutions by Cisco Systems.
Angel continued to form and advise several strong software startups with an emphasis upon ecommerce and merchant services. This led to establishing a highly sought after consulting firm, Codezero Media, that served the online pharmaceutical market. Codezero managed clients processing millions of dollars in online transactions weekly. This culminated in the production of two ecommerce engines that served as the technology foundation through several future Codezero Media related companies. The ecommerce product continues to be updated using recent technologies and is currently being considered for the medical cannabis market. It's sister product to an e-wallet application, which was utilized for several LEC billed products (direct to home phone billing) that together grossed $8 million annually. Other notable online products developed include social, dating, and entertainment websites that have received design awards as well as attention in Rolling Stone magazine. Codezero Media continues to serve as Mr. Stanz's technology incubator.
After standing alongside a family member struggling with cancer, Angel became familiar with effective, but highly under publicized, alternative medical therapies. Inspired by a desire to deliver disruptive technologies that affected human wellness, Angel brought his team's focus to the medical cannabis industry. After working under contract with several prominent medical cannabis brands, development began upon BudGenius.com to address industry gaps and bring further light to the medical efficacy of cannabis. BudGenius.com is now a highly recognized brand to patients, dispensaries, and medical cannabis cultivators. BudGenius.com launched as the first portal for patients to research safe cannabis online, and remains the most highly trafficked website for laboratory services having served over 230 clients in California alone. BudGenius.com continues to develop support technologies for patients, dispensaries, cultivators, and physicians. 2012 will bring office expansions and software licensing to additional state-legal cannabis territories to support emerging regulations that mandate laboratory testing for medical cannabis use.
The discrepancy between federal and state guidelines regarding medical cannabis is recognized. BG Medical Technologies and associated cannabis brands, including BudGenius.com, operate within compliancy to state-specific medical cannabis laws. BG Medical is confident in the longevity of the BudGenius.com brand and services as witnessed by Gallup's recent poll of 50% of USA citizens supporting implementation of legal medical marijuana polices. Currently one third of the USA population resides in a state with legal medical cannabis policies, with recent legislation pending or pursued in the majority of remaining states.
Dec 14, 2011 9:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
FT. LAUDERDALE, Fla., Dec. 14, 2011 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH: PK)
Angel Stanz, CEO of BG Medical Technologies, Inc., represents an accomplished history having held top positions inside several influential technology development firms. During the dot com era, Mr. Stanz served as Senior Research & Development Engineer for CAIS Software Solutions (previously ATCOM/INFO). CAIS became the innovation leader that spearheaded public Internet access solutions, and is responsible for introducing the Internet connector technologies that business travelers enjoy in hotels and cafes across the world daily. Angel worked directly with hardware manufacturers to introduce new protocols to Cisco, 3Com, Cabletron, and Tut Systems microchips that have now become standard features in public access deployments globally. In addition to overseeing high profile installations for Hilton and Marriott brands, he also oversaw the first home-based wifi installations to premier residential properties. A strong focus was placed upon delivering voice/video/data across existing telephone infrastructures utilizing prototype and emergent DSL technologies. Angel also assisted in delivering premier solutions for digitally delivered video content to hotel televisions, a system that has now replaced older VCR decks previously used to queue in-room entertainment. CAIS received investments from Microsoft, KKR ("Kravis, Kohlberg, & Roberts"), and culminated with a successful acquisition of CAIS Software Solutions by Cisco Systems.
Angel continued to form and advise several strong software startups with an emphasis upon ecommerce and merchant services. This led to establishing a highly sought after consulting firm, Codezero Media, that served the online pharmaceutical market. Codezero managed clients processing millions of dollars in online transactions weekly. This culminated in the production of two ecommerce engines that served as the technology foundation through several future Codezero Media related companies. The ecommerce product continues to be updated using recent technologies and is currently being considered for the medical cannabis market. It's sister product to an e-wallet application, which was utilized for several LEC billed products (direct to home phone billing) that together grossed $8 million annually. Other notable online products developed include social, dating, and entertainment websites that have received design awards as well as attention in Rolling Stone magazine. Codezero Media continues to serve as Mr. Stanz's technology incubator.
After standing alongside a family member struggling with cancer, Angel became familiar with effective, but highly under publicized, alternative medical therapies. Inspired by a desire to deliver disruptive technologies that affected human wellness, Angel brought his team's focus to the medical cannabis industry. After working under contract with several prominent medical cannabis brands, development began upon BudGenius.com to address industry gaps and bring further light to the medical efficacy of cannabis. BudGenius.com is now a highly recognized brand to patients, dispensaries, and medical cannabis cultivators. BudGenius.com launched as the first portal for patients to research safe cannabis online, and remains the most highly trafficked website for laboratory services having served over 230 clients in California alone. BudGenius.com continues to develop support technologies for patients, dispensaries, cultivators, and physicians. 2012 will bring office expansions and software licensing to additional state-legal cannabis territories to support emerging regulations that mandate laboratory testing for medical cannabis use.
The discrepancy between federal and state guidelines regarding medical cannabis is recognized. BG Medical Technologies and associated cannabis brands, including BudGenius.com, operate within compliancy to state-specific medical cannabis laws. BG Medical is confident in the longevity of the BudGenius.com brand and services as witnessed by Gallup's recent poll of 50% of USA citizens supporting implementation of legal medical marijuana polices. Currently one third of the USA population resides in a state with legal medical cannabis policies, with recent legislation pending or pursued in the majority of remaining states.
John, I couldn't agree more. I think we need to focus on the company we are in the process of becoming. This company will attract investors IMO. I will repost something I wrote some time back, my feelings haven't changed and I would like to see this discussion begin again.
I don't post much, I prefer to stay out of the fray. But, as I stated in a previous post, I lived for 30 years in Northern California. Long before legalization this area was know for MMJ production. Now with legalization, thousands of people who would have never considered agriculture as a source of income are now part of an army of growers. While it's true there have been raids on all parts of the supply chain, with a little investigation you would find that the people in trouble have let greed lead them outside the spirit of the law. The raids are on grower co-ops who try to produce hundreds of plants in one place. The law states people possessing a prescription can grow ten plants for personal consumption. Now look at this in terms of market forces. As large co-ops find themselves running up against the law, small growers are moving in to take up the slack. Small growers with ten plants can (with the use of info that can be purchased on the Budgenious website) produce up to ten pounds. So now the only way for those thousands of small time growers to separate themselves from the competition is the have their product scientifically tested. Now even as a small time grower you can prove the quality of your product to the dispensaries. The cost of this test is $50. Take a look at the cost of the product at any dispensary site and you will realize the cost of testing is a drop in the bucket. This IS the wave of the future. California will never give up this revenue stream. The state will continue to refine the way that this business is conducted and you can be sure testing of this product will continue and most likely will grow to cover other states as well. That being said I have made profit from RIGH's previous runs and thought I would not look back. But after seeing who the merger was with, and realizing the company was not growing or dispensing, but in fact was a company that would most likely BENEFIT from these crack downs, I have reinvested and I am quite happy to wait for the merger because I believe when we see the financial of this company the PPS will move accordingly. jmho
GLTA Hot
I don't post much, I prefer to stay out of the fray. But, as I stated in a previous post, I lived for 30 years in Northern California. Long before legalization this area was know for MMJ production. Now with legalization, thousands of people who would have never considered agriculture as a source of income are now part of an army of growers. While it's true there have been raids on all parts of the supply chain, with a little investigation you would find that the people in trouble have let greed lead them outside the spirit of the law. The raids are on grower co-ops who try to produce hundreds of plants in one place. The law states people possessing a prescription can grow ten plants for personal consumption. Now look at this in terms of market forces. As large co-ops find themselves running up against the law, small growers are moving in to take up the slack. Small growers with ten plants can (with the use of info that can be purchased on the Budgenious website) produce up to ten pounds. So now the only way for those thousands of small time growers to separate themselves from the competition is the have their product scientifically tested. Now even as a small time grower you can prove the quality of your product to the dispensaries. The cost of this test is $50. Take a look at the cost of the product at any dispensary site and you will realize the cost of testing is a drop in the bucket. This IS the wave of the future. California will never give up this revenue stream. The state will continue to refine the way that this business is conducted and you can be sure testing of this product will continue and most likely will grow to cover other states as well. That being said I have made profit from RIGH's previous runs and thought I would not look back. But after seeing who the merger was with, and realizing the company was not growing or dispensing, but in fact was a company that would most likely BENEFIT from these crack downs, I have reinvested and I am quite happy to wait for the merger because I believe when we see the financial of this company the PPS will move accordingly. jmho
GLTA Hot
RightSmile, Inc. Confirms Reverse Merger Plans with BG Medical Technologies, Inc.
Jan 9, 2012 8:30:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
FORT LAUDERDALE, Fla., Jan. 9, 2012 /PRNewswire/ -- RightSmile, Inc. (Pink Sheets: RIGH) confirms reverse merger plans with BG Medical Technologies, Inc., parent company of popular medical cannabis portal, BudGenius.com.
RightSmile entered into merger discussions in October 2011. Since this time BG Medical has worked to complete an ongoing due diligence study of the public entity and market conditions. Throughout December, RightSmile complied with requests and obligations to prepare the public entity for completion of the merger along with formal exit of the RightSmile management team. Full requirements have now been met to the satisfaction of both companies. Final state and corporate filings in Florida and Nevada are progressing for the respective companies. BG Medical Technologies expects to complete the merger January 18th, 2012. Name change and symbol change requests are to be filed shortly thereafter.
BudGenius.com has served over 240 caregivers for cannabis testing services in California, and provides safety verification and location services for over 2000 patients daily. The company expects to double businesses served and to increase user traffic to over 10,000 visitors daily by mid 2012. Advertising revenue and consumer loyalty programs are being added in Q1, expecting to increase overall revenue 300% by mid-year.
BG Medical Technologies serves its patient community through analysis of responses collected by the BudGenius.com portal in a method similar to traditional scientific trials by harnessing the power of the social Internet. These responses seek to evaluate treatment effectiveness of specific chemical ratios present within the many varieties of cannabis medicine. The resultant data is utilized by BudGenius.com to help guide patients with specific ailments to cannabis medicine varietals that have been evaluated to have a higher probability of favorable treatment.
Services will be expanded throughout 2012 to include diagnostic-support and treatment-monitoring solutions related to cannabis and herbal remedies. These will be introduced as packaged programs to physicians and qualified naturopaths. A program to formulate patient-specific neutraceutical supplements is also underway, and is expected to be introduced by year's end. Supplements will include cannabis and non-cannabis related herbal compounds.
BG Medical Technologies is committed to providing options to patients seeking alternative and supplement treatment to traditional pharmaceutical therapy for critical ailments and general wellness.
None of the statements above made above have been evaluated by the FDA. Furthermore, none of the
Jan 9, 2012 8:30:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
FORT LAUDERDALE, Fla., Jan. 9, 2012 /PRNewswire/ -- RightSmile, Inc. (Pink Sheets: RIGH) confirms reverse merger plans with BG Medical Technologies, Inc., parent company of popular medical cannabis portal, BudGenius.com.
RightSmile entered into merger discussions in October 2011. Since this time BG Medical has worked to complete an ongoing due diligence study of the public entity and market conditions. Throughout December, RightSmile complied with requests and obligations to prepare the public entity for completion of the merger along with formal exit of the RightSmile management team. Full requirements have now been met to the satisfaction of both companies. Final state and corporate filings in Florida and Nevada are progressing for the respective companies. BG Medical Technologies expects to complete the merger January 18th, 2012. Name change and symbol change requests are to be filed shortly thereafter.
BudGenius.com has served over 240 caregivers for cannabis testing services in California, and provides safety verification and location services for over 2000 patients daily. The company expects to double businesses served and to increase user traffic to over 10,000 visitors daily by mid 2012. Advertising revenue and consumer loyalty programs are being added in Q1, expecting to increase overall revenue 300% by mid-year.
BG Medical Technologies serves its patient community through analysis of responses collected by the BudGenius.com portal in a method similar to traditional scientific trials by harnessing the power of the social Internet. These responses seek to evaluate treatment effectiveness of specific chemical ratios present within the many varieties of cannabis medicine. The resultant data is utilized by BudGenius.com to help guide patients with specific ailments to cannabis medicine varietals that have been evaluated to have a higher probability of favorable treatment.
Services will be expanded throughout 2012 to include diagnostic-support and treatment-monitoring solutions related to cannabis and herbal remedies. These will be introduced as packaged programs to physicians and qualified naturopaths. A program to formulate patient-specific neutraceutical supplements is also underway, and is expected to be introduced by year's end. Supplements will include cannabis and non-cannabis related herbal compounds.
BG Medical Technologies is committed to providing options to patients seeking alternative and supplement treatment to traditional pharmaceutical therapy for critical ailments and general wellness.
None of the statements above made above have been evaluated by the FDA. Furthermore, none of the
hallo,
heute hatten wir ein riesen volumen,am 18.01.12 findet der merger mi budgenius statt denke das könnte ein 10bagger werden,
Points
So, I visited BG's site. In my own curiosity I began to rifle through the different strains they had to offer. About a minute in, a little in-window pop-up screen appeared. It wanted me to make an account, so I thought, why not. I latter discovered "BudPoints" which I found to be a very interesting way to get exposure through social networking sites like Facebook, Twitter and others. They also supposedly have T-shirts, hats, etc. that you can get in exchange for the BudPoints. I'm not aware that any other medical cannabis company utilizes social networking. This might give BG that edge that pushes them forward and past the competition in the future as this company continues to develop.
If anyone would like to check this out for themselves go here > http://budgenius.com/h
heute hatten wir ein riesen volumen,am 18.01.12 findet der merger mi budgenius statt denke das könnte ein 10bagger werden,
Points
So, I visited BG's site. In my own curiosity I began to rifle through the different strains they had to offer. About a minute in, a little in-window pop-up screen appeared. It wanted me to make an account, so I thought, why not. I latter discovered "BudPoints" which I found to be a very interesting way to get exposure through social networking sites like Facebook, Twitter and others. They also supposedly have T-shirts, hats, etc. that you can get in exchange for the BudPoints. I'm not aware that any other medical cannabis company utilizes social networking. This might give BG that edge that pushes them forward and past the competition in the future as this company continues to develop.
If anyone would like to check this out for themselves go here > http://budgenius.com/h
The transition is not suppose to take effect until later this month. From that point forward, Angel will be the CEO and any connections with BCAP will no longer apply. On the conference call we were assured that the A/S is still around 2 billion shares, we were not told what the O/S was. We were also assured there will be no Reverse Split done afterwords either. Here is the information so you can listen to the existing CEO introduce the new CEO and Angels plan for the company.
http://webcache.googleusercontent.com/search?q=cache:I8OLae_…
Then Scroll down to -> Conference Call - December 14th
From what I extrapolated from the call; Angel will continue to do MM testing and will also be developing legal derivatives to be used in other products, for example bath and body, and herbal remedies. The website you can look at for the MM Testing is: http://budgenius.com/
So right now, expect a lot of the same. The tick/flips are in control till further information and the transition is complete.
http://webcache.googleusercontent.com/search?q=cache:I8OLae_…
Then Scroll down to -> Conference Call - December 14th
From what I extrapolated from the call; Angel will continue to do MM testing and will also be developing legal derivatives to be used in other products, for example bath and body, and herbal remedies. The website you can look at for the MM Testing is: http://budgenius.com/
So right now, expect a lot of the same. The tick/flips are in control till further information and the transition is complete.
0.0003-0.0004 vol.203,000,000
einen tag vor dem merger
einen tag vor dem merger
0.0004-0.0005 vol. 305,000,000
R/M news set for end of close today for RIGH
ightSmile Announces Completion of Reverse Merger With BudGenius
Jan 18, 2012 5:56:00 PM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Jan. 18, 2012 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH:PK) is pleased to announce the Company has fully executed all documents and completed the reverse merger with BG Medical Technologies, Inc., parent company of popular medical cannabis portal, BudGenius.com.
As per the terms of the closing agreement, Randy Schneider has resigned from all positions of the company, while Aaron Stanz, CEO of BG Medical Technologies, Inc., was elected as the new CEO and Director of RightSmile, Inc.
The transaction was completed for a combination of newly issued Preferred and Common shares of RightSmile for 100% of all the outstanding shares of BG Medical.
Aaron Stanz the new CEO will issue a more detailed press release in the morning.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Randy Schneider
561-404-4895
SOURCE RightSmile, Inc.
Jan 18, 2012 5:56:00 PM
Close Ad
Email story | Discuss on ZenoBank | View more ads
BOCA RATON, Fla., Jan. 18, 2012 /PRNewswire/ -- RightSmile, Inc. (OTC:RIGH:PK) is pleased to announce the Company has fully executed all documents and completed the reverse merger with BG Medical Technologies, Inc., parent company of popular medical cannabis portal, BudGenius.com.
As per the terms of the closing agreement, Randy Schneider has resigned from all positions of the company, while Aaron Stanz, CEO of BG Medical Technologies, Inc., was elected as the new CEO and Director of RightSmile, Inc.
The transaction was completed for a combination of newly issued Preferred and Common shares of RightSmile for 100% of all the outstanding shares of BG Medical.
Aaron Stanz the new CEO will issue a more detailed press release in the morning.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Contact:
Randy Schneider
561-404-4895
SOURCE RightSmile, Inc.
LOS ANGELES, Jan. 19, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) announces the successful completion of a reverse merger with RightSmile, Inc. BG Medical, headquartered in Los Angeles, California, will operate under the leadership of a new management team led by Chief Executive Officer, Angel Stanz. The Company is working with counsel to file the appropriate documents with FINRA to promptly complete its formal name and symbol change.
BG Medical Technologies, Inc. has exchanged 100% of its outstanding shares for 4 million shares of preferred stock and 200 million shares of restricted common stock. Currently the Company does not have authorized shares remaining to issue BG Medical required stock and will look to increase its authorized shares to issue restricted shares to BG Medical. BG Medical plans to use stock options as incentives to attract seasoned talent to its workforce. This will enable the Company to accelerate development and expedite its future business plans. BG Medical will also resume the task of uplisting the Company to the OTC Bulletin Board by engaging the team that began an audit in 2010.
BG Medical is a technology and services provider for the medical cannabis industry. The company delivers an educational consumer experience through an expanding suite of software and services. BG Medical's flagship brand, BudGenius.com, is an online portal providing medicine matching and directory services enabling patients to select and locate the most effective cannabis for their ailments. BG Laboratories provides potency, pesticide, and contaminant analysis reporting for medical cannabis. BG Medical has provided testing services for over 240 cannabis dispensaries, farmers, and product manufacturers. BudGenius.com receives over 2,000 visits daily from patients looking to locate applicable medicine for their medical needs.
The Company completed 3,000 cannabis tests for year ending 2011, and projects over 10,000 cannabis tests for year 2012. BG Medical will capitalize on new 2012 revenue streams in targeted advertising programs for web and video, the launch of an on-demand video network, software licensing revenue, and patient loyalty programs. BG Medical adds $662,000 in assets to the current balance sheet of the public entity as well as projected revenues for 2012 upwards of $6,500,000. Full revenue stream projections will be released on or prior to February 1st.
BG Medical Technologies does not sell, grow, harvest, cultivate, nor distribute med
BG Medical Technologies, Inc. has exchanged 100% of its outstanding shares for 4 million shares of preferred stock and 200 million shares of restricted common stock. Currently the Company does not have authorized shares remaining to issue BG Medical required stock and will look to increase its authorized shares to issue restricted shares to BG Medical. BG Medical plans to use stock options as incentives to attract seasoned talent to its workforce. This will enable the Company to accelerate development and expedite its future business plans. BG Medical will also resume the task of uplisting the Company to the OTC Bulletin Board by engaging the team that began an audit in 2010.
BG Medical is a technology and services provider for the medical cannabis industry. The company delivers an educational consumer experience through an expanding suite of software and services. BG Medical's flagship brand, BudGenius.com, is an online portal providing medicine matching and directory services enabling patients to select and locate the most effective cannabis for their ailments. BG Laboratories provides potency, pesticide, and contaminant analysis reporting for medical cannabis. BG Medical has provided testing services for over 240 cannabis dispensaries, farmers, and product manufacturers. BudGenius.com receives over 2,000 visits daily from patients looking to locate applicable medicine for their medical needs.
The Company completed 3,000 cannabis tests for year ending 2011, and projects over 10,000 cannabis tests for year 2012. BG Medical will capitalize on new 2012 revenue streams in targeted advertising programs for web and video, the launch of an on-demand video network, software licensing revenue, and patient loyalty programs. BG Medical adds $662,000 in assets to the current balance sheet of the public entity as well as projected revenues for 2012 upwards of $6,500,000. Full revenue stream projections will be released on or prior to February 1st.
BG Medical Technologies does not sell, grow, harvest, cultivate, nor distribute med
0.0007
BG Medical Technologies Issues Update
Jan 25, 2012 8:30:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Jan. 25, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) has concluded its recent reverse merger transaction and continues to complete filings to bring the public entity into full operational status under new executive management.
BG Medical Technologies has filed amendments to update company subsidiaries in Florida and has assumed control of all related assets, pursuant to the complete replacement of the previous management team and RightSmile, Inc. The company will be filing in Nevada to update and amend the public entity by end of week. Upon verified completion of these updates, the company will focus on filing with FINRA for its name and symbol change.
Following the symbol change, the company expects to release ongoing information throughout Q1 related to financial projections, notable officer and executive appointments, imperative technology releases, and investor relations.
The company thanks the new and current shareholders for their ongoing interests as the course of the public entity is steered into the medical cannabis industry. "The response to the reverse merger has been extremely positive," explains CEO Angel Stanz. "I've spoken to many shareholders eager for additional information. However, due to regulations, we are bound to direct them only to previously disclosed information. We too are excited for a bright future, and new information will be released as soon as the transition process is complete."
Jan 25, 2012 8:30:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Jan. 25, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) has concluded its recent reverse merger transaction and continues to complete filings to bring the public entity into full operational status under new executive management.
BG Medical Technologies has filed amendments to update company subsidiaries in Florida and has assumed control of all related assets, pursuant to the complete replacement of the previous management team and RightSmile, Inc. The company will be filing in Nevada to update and amend the public entity by end of week. Upon verified completion of these updates, the company will focus on filing with FINRA for its name and symbol change.
Following the symbol change, the company expects to release ongoing information throughout Q1 related to financial projections, notable officer and executive appointments, imperative technology releases, and investor relations.
The company thanks the new and current shareholders for their ongoing interests as the course of the public entity is steered into the medical cannabis industry. "The response to the reverse merger has been extremely positive," explains CEO Angel Stanz. "I've spoken to many shareholders eager for additional information. However, due to regulations, we are bound to direct them only to previously disclosed information. We too are excited for a bright future, and new information will be released as soon as the transition process is complete."
BG Medical Technologies Reveals 2012 Fiscal Year Strategy
Feb 1, 2012 8:50:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 1, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) has positioned itself as a publicly-traded technology leader in medical cannabis and would like to take the time to discuss its 2012 fiscal growth strategy for shareholders and media interests.
The global vision of BG Medical is to empower individuals to be fully responsible for their personal wellness. This is accomplished through the combination of technology and media developments in three primary divisions: laboratory analysis, business support tools, and data services. The company's operational strategy is comprised of a wide variety of herbal and nutraceutical programs.
BG Medical recognizes the medical marijuana industry as an under-developed technology market capable of supporting high-yield growth. The strong social involvement of cannabis patients also serves as an optimum market for BG Medical to introduce Internet-based wellness programs. BG Medical has seized this opportunity and is best known for its popular portal for medical cannabis treatment, BudGenius.com, a provider of safety and potency testing services. Currently less than 10% of all medical cannabis consumed worldwide is laboratory tested. BG Medical estimates that cannabis testing services currently represent a $50M market. Cannabis-related advertising is estimated to grow beyond $150M in 2013. Market surveys have stated that the USA cannabis industry is expected to grow 400% by 2016.
BG Medical confirms its previously expressed $6.5M revenue projection for fiscal 2012. This is to be obtained through testing services, advertising revenue, and cloud-based software services. BudGenius will aggressively enter the advertising market utilizing its growing user base to accelerate revenue growth. New business support tools will be introduced to caregivers supporting cost reduction in operations, thus freeing up financial resources for additional testing. A strong expansion into content publishing and on-demand media monetization will also be introduced.
The remainder of Q1 will be comprised of staff growth, office relocation upgrades, and administration of the new public entity. Q2 and Q3 will represent strong development focus on new technologies, and additional sales strategies. Executive staff leadership have recently been added with deep experience in major network media production, investment advisory, cannabis advocacy, and public company management from notable cannabis industry brands. These announcements will be released shortly.
In Q4 BudGenius.com will make an unprecedented announcement that will introduce an affordable testing program to cannabis collectives that is expected to radically transform the industry by sustaining upwards of a 90% tested medicine catalog nationwide by mid-2013. This will be accomplished through direct service and partner programs. This solution will also serve as the business catalyst to fully solve any revenue concerns related to dispensary turnover stemming from fluctuating federal policy. BudGenius backs this bold statement with its history of delivering first-to-market innovative solutions, including serving as the first online database of searchable tested cannabis medicine.
BG Medical Technologies, Inc. stands firmly in its commitment to make safe and medically relevant treatment options available to all cannabis patients nationwide.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
BG Medical Technologies does not sell, grow, harvest, cultivate, nor distribute
Feb 1, 2012 8:50:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 1, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) has positioned itself as a publicly-traded technology leader in medical cannabis and would like to take the time to discuss its 2012 fiscal growth strategy for shareholders and media interests.
The global vision of BG Medical is to empower individuals to be fully responsible for their personal wellness. This is accomplished through the combination of technology and media developments in three primary divisions: laboratory analysis, business support tools, and data services. The company's operational strategy is comprised of a wide variety of herbal and nutraceutical programs.
BG Medical recognizes the medical marijuana industry as an under-developed technology market capable of supporting high-yield growth. The strong social involvement of cannabis patients also serves as an optimum market for BG Medical to introduce Internet-based wellness programs. BG Medical has seized this opportunity and is best known for its popular portal for medical cannabis treatment, BudGenius.com, a provider of safety and potency testing services. Currently less than 10% of all medical cannabis consumed worldwide is laboratory tested. BG Medical estimates that cannabis testing services currently represent a $50M market. Cannabis-related advertising is estimated to grow beyond $150M in 2013. Market surveys have stated that the USA cannabis industry is expected to grow 400% by 2016.
BG Medical confirms its previously expressed $6.5M revenue projection for fiscal 2012. This is to be obtained through testing services, advertising revenue, and cloud-based software services. BudGenius will aggressively enter the advertising market utilizing its growing user base to accelerate revenue growth. New business support tools will be introduced to caregivers supporting cost reduction in operations, thus freeing up financial resources for additional testing. A strong expansion into content publishing and on-demand media monetization will also be introduced.
The remainder of Q1 will be comprised of staff growth, office relocation upgrades, and administration of the new public entity. Q2 and Q3 will represent strong development focus on new technologies, and additional sales strategies. Executive staff leadership have recently been added with deep experience in major network media production, investment advisory, cannabis advocacy, and public company management from notable cannabis industry brands. These announcements will be released shortly.
In Q4 BudGenius.com will make an unprecedented announcement that will introduce an affordable testing program to cannabis collectives that is expected to radically transform the industry by sustaining upwards of a 90% tested medicine catalog nationwide by mid-2013. This will be accomplished through direct service and partner programs. This solution will also serve as the business catalyst to fully solve any revenue concerns related to dispensary turnover stemming from fluctuating federal policy. BudGenius backs this bold statement with its history of delivering first-to-market innovative solutions, including serving as the first online database of searchable tested cannabis medicine.
BG Medical Technologies, Inc. stands firmly in its commitment to make safe and medically relevant treatment options available to all cannabis patients nationwide.
The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
BG Medical Technologies does not sell, grow, harvest, cultivate, nor distribute
BG Medical Technologies Announces Corporate Insight Website
Feb 15, 2012 9:33:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 15, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH), a leading provider of business solutions to the medical cannabis industry, announces the launch date for its new corporate website, www.bgmedtech.com.
On February 22, 2012 9:30 AM ET, BG Medical will illustrate its ongoing focus to alternative medicine solutions, cannabis technologies, and its inspiring corporate vision for 2015. Valuable information pertaining to shareholders, prospective investors, patients, doctors, and entrepreneurs, will be shared to draw emphasis to the emergent cannabis industry and highlight the positive impacts BG Medical is introducing to the community.
"This new site represents our commitment to company shareholders by placing exciting and relevant information directly at their fingertips," stated Angel Stanz, CEO. "We're committed to building the most informative communication center ever witnessed for a publicly-traded cannabis company."
The site will be comprised of several sections, each growing outward from the corporate vision statement. Currently available products and services will be highlighted in detail. Products currently in development will be featured. An extensive investor relations section will be established for quotes, charts, historical data, reports, and filings. A comprehensive press room will include all previous releases and newly associated articles. An investor Q&A section will be added for the purpose of bringing clarity to shareholders that may not be familiar with state-legal cannabis policies. Editorialized content will also be written to clarify the company's position on relevant topics.
Bgmedtech.com represents the Company's commitment to a rapidly emerging industry that has the potential to contribute significantly to economies, the environment, and the people of the world.
Feb 15, 2012 9:33:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 15, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH), a leading provider of business solutions to the medical cannabis industry, announces the launch date for its new corporate website, www.bgmedtech.com.
On February 22, 2012 9:30 AM ET, BG Medical will illustrate its ongoing focus to alternative medicine solutions, cannabis technologies, and its inspiring corporate vision for 2015. Valuable information pertaining to shareholders, prospective investors, patients, doctors, and entrepreneurs, will be shared to draw emphasis to the emergent cannabis industry and highlight the positive impacts BG Medical is introducing to the community.
"This new site represents our commitment to company shareholders by placing exciting and relevant information directly at their fingertips," stated Angel Stanz, CEO. "We're committed to building the most informative communication center ever witnessed for a publicly-traded cannabis company."
The site will be comprised of several sections, each growing outward from the corporate vision statement. Currently available products and services will be highlighted in detail. Products currently in development will be featured. An extensive investor relations section will be established for quotes, charts, historical data, reports, and filings. A comprehensive press room will include all previous releases and newly associated articles. An investor Q&A section will be added for the purpose of bringing clarity to shareholders that may not be familiar with state-legal cannabis policies. Editorialized content will also be written to clarify the company's position on relevant topics.
Bgmedtech.com represents the Company's commitment to a rapidly emerging industry that has the potential to contribute significantly to economies, the environment, and the people of the world.
Technology Leader Begins Development on Diagnostic Hardware to Support Medical Marijuana Treatment for Cancer and Critical Illnesses
BG Medical Technologies combines laboratory research, Internet cloud technologies, and medical diagnostics for a data-based approach to medical marijuana treatment programs.
Feb 27, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 27, 2012 /PRNewswire/ -- BG Medical Technologies (OTC: RIGH) has announced development of a USB-enabled diagnostic support device that will facilitate patients suffering from critical illnesses such as cancer, to match the most effective plant variants for physician-recommended medical marijuana treatments. The device will collect patient data in a non-invasive manner by detecting subtle shifts in the patient's physiology and then upload encrypted data to HIPAA-compliant servers for further analysis and physician review. Physicians will interact with patients and data history through a bundled video conferencing application. This will offer patients the ability to discreetly pursue medical marijuana treatment from the privacy of their home. For states with telemedicine restrictions, services will be made available for use within physician offices. This system also seeks to improve medical marijuana treatment programs by involving physicians more than once per year to better evaluate treatment effectiveness and applicability.
The diagnostic support system works in tandem with BG Medical's BudGenius.com laboratory research and ongoing data collection to identify marijuana strains that present the most beneficial ratios of medicinal compounds that are likely to best serve the patient's needs. Medicine locator services will also be used to locate cannabis strains currently available within the patient's travel radius. BudGenius services will continue to be expanded with new features to support the diagnostic system development, and will be further enhanced with new technology partnerships. BG Medical has stated that this announcement fulfills another component of their "natural medicine trifecta", an empirical data approach to administering natural medical marijuana treatments, as detailed in their product strategy guide.
"While our competitors are seeking to create pharmaceuticals that divide and isolate the helpful compounds in cannabis, we will continue to focus on systems that support treatments with organically developed medicines that are genetically predisposed to treat specific ailments in their natural form," adds Angel Stanz, CEO. "In the shadow of a failed healthcare system rife with expensive and toxic treatments, we believe the convergence of nature and Internet technologies will form the future of affordable preventative and curative medicine."
The USB hardware device is based upon technologies previously authorized by the FDA to enter clinical trials for determining its effectiveness in breast cancer diagnosis. BG Medical Technologies will seek FDA approval of the final hardware implementation as a diagnostic support device.
BG Medical Technologies combines laboratory research, Internet cloud technologies, and medical diagnostics for a data-based approach to medical marijuana treatment programs.
Feb 27, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 27, 2012 /PRNewswire/ -- BG Medical Technologies (OTC: RIGH) has announced development of a USB-enabled diagnostic support device that will facilitate patients suffering from critical illnesses such as cancer, to match the most effective plant variants for physician-recommended medical marijuana treatments. The device will collect patient data in a non-invasive manner by detecting subtle shifts in the patient's physiology and then upload encrypted data to HIPAA-compliant servers for further analysis and physician review. Physicians will interact with patients and data history through a bundled video conferencing application. This will offer patients the ability to discreetly pursue medical marijuana treatment from the privacy of their home. For states with telemedicine restrictions, services will be made available for use within physician offices. This system also seeks to improve medical marijuana treatment programs by involving physicians more than once per year to better evaluate treatment effectiveness and applicability.
The diagnostic support system works in tandem with BG Medical's BudGenius.com laboratory research and ongoing data collection to identify marijuana strains that present the most beneficial ratios of medicinal compounds that are likely to best serve the patient's needs. Medicine locator services will also be used to locate cannabis strains currently available within the patient's travel radius. BudGenius services will continue to be expanded with new features to support the diagnostic system development, and will be further enhanced with new technology partnerships. BG Medical has stated that this announcement fulfills another component of their "natural medicine trifecta", an empirical data approach to administering natural medical marijuana treatments, as detailed in their product strategy guide.
"While our competitors are seeking to create pharmaceuticals that divide and isolate the helpful compounds in cannabis, we will continue to focus on systems that support treatments with organically developed medicines that are genetically predisposed to treat specific ailments in their natural form," adds Angel Stanz, CEO. "In the shadow of a failed healthcare system rife with expensive and toxic treatments, we believe the convergence of nature and Internet technologies will form the future of affordable preventative and curative medicine."
The USB hardware device is based upon technologies previously authorized by the FDA to enter clinical trials for determining its effectiveness in breast cancer diagnosis. BG Medical Technologies will seek FDA approval of the final hardware implementation as a diagnostic support device.
Share Structure
Market Value1 $723,497 a/o Feb 24, 2012
Shares Outstanding 2,411,657,296 a/o Dec 30, 2011
Float 2,411,657,296 a/o Dec 30, 2011
Authorized Shares 2,500,000,000 a/o Sep 30, 2011
Par Value 0.001
Market Value1 $723,497 a/o Feb 24, 2012
Shares Outstanding 2,411,657,296 a/o Dec 30, 2011
Float 2,411,657,296 a/o Dec 30, 2011
Authorized Shares 2,500,000,000 a/o Sep 30, 2011
Par Value 0.001
SK 0.0004 plus 33% vol.170,000,000
Antwort auf Beitrag Nr.: 42.814.809 von Wohnwunsch am 27.02.12 20:43:31auch wenn es eine schrottbude ist,in der USA wachsen MARIHUANA APOTHEKEN wie pilze aus dem boden und in CALIFORNIEN ist es legal in der APOTHEKEN MARIHUANA für medizinische zwecken zu kaufen und die webseite http://www.bgmedtech.com/ wird bald der renner.
TeleHealthcare Systems from BG Medical Technologies to Reduce Patient Healthcare Costs and Improve Lives
Organic medicine goes "high" tech with medical marijuana, natural herbs, and Internet technology.
Feb 29, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 29, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) is set to engage an $11 billion dollar tele-healthcare market in addition to the projected $14 billion dollar medical marijuana market, with Internet and smartphone applications to support growing trends of natural medicine and wellness care.
Healthcare costs in the United States are some of the highest in the world leaving many Americans uninsured, under-insured, or living in communities without access to affordable care. This problem worsens as US healthcare costs continue to rise each year. For those who can afford healthcare, new problems are introduced. The Centers for Disease Control and Prevention report that half of all Americans will be diagnosed with a mental illness during their lifetime. Celebrity prescription drug deaths dominate media headlines, and pharmaceutical-related drug deaths now outnumber traffic fatalities in the United States.
BG Medical Technologies is introducing safe and affordable alternatives to traditional healthcare with Internet-based applications that support nutraceutical and medical marijuana treatments. Recently the company announced development of a diagnostic device that is designed to provide physicians with data to chart medical marijuana effectiveness over time. These systems will be made available to marijuana-recommending doctors and will include the ability to instantly link diagnostic data to a remote network of naturopathy doctors for further on-site and remote patient care. Patients will be apprised of additional diagnostic findings and be given the option to pursue adjunct natural therapies in addition to medical marijuana treatments.
"We've all had the experience of having our car serviced for a noticeable problem only to learn that once the mechanic examined under the hood, more parts were wearing out that endangered our safety," stated Angel Stanz, CEO. "We are making this type of preventative maintenance available to everyone. This is expected to save tens of thousands of dollars in out-of-pocket healthcare expenses per patient."
BG Medical is designing these systems to reduce patient costs while providing additional shared revenue to participating medical marijuana doctors, caregivers, and licensed naturopath physicians. More information on how this technology will interact with patients and doctors can be found in the company's articles section of their corporate website.
Organic medicine goes "high" tech with medical marijuana, natural herbs, and Internet technology.
Feb 29, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, Feb. 29, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) is set to engage an $11 billion dollar tele-healthcare market in addition to the projected $14 billion dollar medical marijuana market, with Internet and smartphone applications to support growing trends of natural medicine and wellness care.
Healthcare costs in the United States are some of the highest in the world leaving many Americans uninsured, under-insured, or living in communities without access to affordable care. This problem worsens as US healthcare costs continue to rise each year. For those who can afford healthcare, new problems are introduced. The Centers for Disease Control and Prevention report that half of all Americans will be diagnosed with a mental illness during their lifetime. Celebrity prescription drug deaths dominate media headlines, and pharmaceutical-related drug deaths now outnumber traffic fatalities in the United States.
BG Medical Technologies is introducing safe and affordable alternatives to traditional healthcare with Internet-based applications that support nutraceutical and medical marijuana treatments. Recently the company announced development of a diagnostic device that is designed to provide physicians with data to chart medical marijuana effectiveness over time. These systems will be made available to marijuana-recommending doctors and will include the ability to instantly link diagnostic data to a remote network of naturopathy doctors for further on-site and remote patient care. Patients will be apprised of additional diagnostic findings and be given the option to pursue adjunct natural therapies in addition to medical marijuana treatments.
"We've all had the experience of having our car serviced for a noticeable problem only to learn that once the mechanic examined under the hood, more parts were wearing out that endangered our safety," stated Angel Stanz, CEO. "We are making this type of preventative maintenance available to everyone. This is expected to save tens of thousands of dollars in out-of-pocket healthcare expenses per patient."
BG Medical is designing these systems to reduce patient costs while providing additional shared revenue to participating medical marijuana doctors, caregivers, and licensed naturopath physicians. More information on how this technology will interact with patients and doctors can be found in the company's articles section of their corporate website.
0.0005 vol 360,000,000
6 500 000 $/year : 3.3 B AS (this is with the AS maxed out, which is NOT the case, additional shares will be restricted) = 0.00196/share : 25% net profit (a guess) = +- 0.00049/net worth x PE 15 = 0.00735 $ a share
Anyway UNDERVALUED imo
GO RIGH
Anyway UNDERVALUED imo
GO RIGH
RIGH MAJOR DD >>> NEXT BIG CANNABIS RUNNER DD $$$<<<
CBIS,MJNA big runners >>RIGH is the next BIG ONE
yesterday RIGH has traded 410 million shares and ended up 66 %
RIGH is taking it the the NEXT LEVEL
new SYMBOL COMING+NEW NAME + NEW CUSIP
HUGE NEWS FLOW >>>
-TeleHealthcare Systems from BG Medical Technologies to Reduce Patient Healthcare Costs and Improve Lives
http://ih.advfn.com/p.php?pid=nmona&article=51413108
-Technology Leader Begins Development on Diagnostic Hardware to Support Medical Marijuana Treatment for Cancer and Critical Il...
http://ih.advfn.com/p.php?pid=nmona&article=51369492
-BG Medical Technologies Launches Corporate Website for Medical Marijuana Investors
http://ih.advfn.com/p.php?pid=nmona&article=51301656
-BG Medical Technologies, Inc. and BudGenius.com Successfully Complete Reverse Merger to Service Multi-Billion Dollar Cannabis...
http://ih.advfn.com/p.php?pid=nmona&article=50810766
with RIGH in the CANABIS TREND of plays and is expecting to get a NEW SYMBOL ,NEW NAME ,NEW CUSIP
WATCH FOR A MAJOR SHORT COVERING ON IT AND A MAJOR RUN
CBIS,MJNA big runners >>RIGH is the next BIG ONE
yesterday RIGH has traded 410 million shares and ended up 66 %
RIGH is taking it the the NEXT LEVEL
new SYMBOL COMING+NEW NAME + NEW CUSIP
HUGE NEWS FLOW >>>
-TeleHealthcare Systems from BG Medical Technologies to Reduce Patient Healthcare Costs and Improve Lives
http://ih.advfn.com/p.php?pid=nmona&article=51413108
-Technology Leader Begins Development on Diagnostic Hardware to Support Medical Marijuana Treatment for Cancer and Critical Il...
http://ih.advfn.com/p.php?pid=nmona&article=51369492
-BG Medical Technologies Launches Corporate Website for Medical Marijuana Investors
http://ih.advfn.com/p.php?pid=nmona&article=51301656
-BG Medical Technologies, Inc. and BudGenius.com Successfully Complete Reverse Merger to Service Multi-Billion Dollar Cannabis...
http://ih.advfn.com/p.php?pid=nmona&article=50810766
with RIGH in the CANABIS TREND of plays and is expecting to get a NEW SYMBOL ,NEW NAME ,NEW CUSIP
WATCH FOR A MAJOR SHORT COVERING ON IT AND A MAJOR RUN
A few things to keep in mind..
Cannabis is closer to full national legalization than ever before. There are currently 16 states with medical marijuana (Arizona being the latest in this trend) and 17 states with pending ballots. Aside from medical marijuana states are also petitioning the federal government for regulations as in the case of alcohol.
16 States with medicinal marijuana http://medicalmarijuana.procon.org/view.resource.php?resourc…
Alaska, Arizona, California, Colorado, DC, Delaware, Hawaii, Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington.
17 States with Pending Legislation to Legalize Medical Marijuana
(as of Feb. 13, 2012)
Alabama, Idaho, Illinois, Indiana, Iowa, Kansas, Maryland, Massachusetts, Mississippi, Missouri, New Hampshire, New York, Ohio, Oklahoma, Pennsylvania, West Virginia and Wisconsin
"DENVER, COLORADO--(ENEWSPF)--February 28, 2012. Yesterday, Colorado Secretary of State Scott Gessler announced that the initiative to make adult use of marijuana legal and regulate it in a manner similarly to alcohol received enough signatures to qualify for the state ballot in November. In a Statement of Sufficiency released this afternoon, Sec. Gessler reported that the Campaign to Regulate Marijuana Like Alcohol turned in more than the required number of valid signatures to qualify for the ballot. Voters in Colorado will have the opportunity to vote on this measure on November 6 of this year."
http://www.enewspf.com/latest-news/latest-national/31238-col…
In August of 2008 I was involved in a rear-end accident and broke my back. My lower spine is so contorted you can see the bones leaning to the right. After months of painful therapy and the fear of back operations I was prescribed countless medications to help control the pain. Some morning I would wake up without the use of my legs regardless of the amount of medication I would take, nothing would help with the pain, just slightly dull it. Along with the pain I was going through on a daily basis I was more than overcome with nausea from the pills I was prescribed. After months and months of sickness and countless different pain pills I decided to try something new..
I am now a medical marijuana patient, and haven't taken a pain pill in months! Therefor I know the solutions and benefits it offers to users who are or used to being bound to pain pills. The effects are amazing (and I'm not referring to the high). I now spend most of my days playing with my kids and enjoying the freedom I missed out on before.
I'm not here to pump this stock, it looks like it doesn't need my help anyways. I'm just here to let you guys know that cannabis is no longer the "drug" it was made out to be during the days of Marijuana Madness..
Good luck to everyone who is active in this stock.
Cannabis is closer to full national legalization than ever before. There are currently 16 states with medical marijuana (Arizona being the latest in this trend) and 17 states with pending ballots. Aside from medical marijuana states are also petitioning the federal government for regulations as in the case of alcohol.
16 States with medicinal marijuana http://medicalmarijuana.procon.org/view.resource.php?resourc…
Alaska, Arizona, California, Colorado, DC, Delaware, Hawaii, Maine, Michigan, Montana, Nevada, New Jersey, New Mexico, Oregon, Rhode Island, Vermont and Washington.
17 States with Pending Legislation to Legalize Medical Marijuana
(as of Feb. 13, 2012)
Alabama, Idaho, Illinois, Indiana, Iowa, Kansas, Maryland, Massachusetts, Mississippi, Missouri, New Hampshire, New York, Ohio, Oklahoma, Pennsylvania, West Virginia and Wisconsin
"DENVER, COLORADO--(ENEWSPF)--February 28, 2012. Yesterday, Colorado Secretary of State Scott Gessler announced that the initiative to make adult use of marijuana legal and regulate it in a manner similarly to alcohol received enough signatures to qualify for the state ballot in November. In a Statement of Sufficiency released this afternoon, Sec. Gessler reported that the Campaign to Regulate Marijuana Like Alcohol turned in more than the required number of valid signatures to qualify for the ballot. Voters in Colorado will have the opportunity to vote on this measure on November 6 of this year."
http://www.enewspf.com/latest-news/latest-national/31238-col…
In August of 2008 I was involved in a rear-end accident and broke my back. My lower spine is so contorted you can see the bones leaning to the right. After months of painful therapy and the fear of back operations I was prescribed countless medications to help control the pain. Some morning I would wake up without the use of my legs regardless of the amount of medication I would take, nothing would help with the pain, just slightly dull it. Along with the pain I was going through on a daily basis I was more than overcome with nausea from the pills I was prescribed. After months and months of sickness and countless different pain pills I decided to try something new..
I am now a medical marijuana patient, and haven't taken a pain pill in months! Therefor I know the solutions and benefits it offers to users who are or used to being bound to pain pills. The effects are amazing (and I'm not referring to the high). I now spend most of my days playing with my kids and enjoying the freedom I missed out on before.
I'm not here to pump this stock, it looks like it doesn't need my help anyways. I'm just here to let you guys know that cannabis is no longer the "drug" it was made out to be during the days of Marijuana Madness..
Good luck to everyone who is active in this stock.
BG Medical Technologies Announces Expansion Plans to New Headquarters for Supporting Growth
BG Medical Technologies new location to support additional staff and planned capacity growth for laboratory services, media production, and customer support.
Mar 6, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, March 6, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) today announces the relocation to new corporate headquarters for accommodating its rapid growth and future expansion plans. These new facilities will provide increased capacity for medical marijuana laboratory testing, developing natural medicine solutions, media production, content creation, sales, and leadership functions across the company.
The newly designed laboratory is configured to work in tandem with BudGenius software upgrades aimed at significantly increasing labor efficiency across a network of integrated hardware. The new laboratory will also support added technologies for increased data collection. Dedicated media suites for educational video production are being established, along with an HD post-production facility for onsite video and audio editing. An expanded sales area has been selected to house regional trainings, and also to support call center growth through 2015.
"This new and creative space greatly increases our capabilities and aligns us with our ongoing growth. We expected this to build upon team synergies while providing our staff the resources to rapidly develop new technologies for medical marijuana and natural medicines," said Angel Stanz, Chief Executive Officer for BG Medical Technologies. "Our team is excited about the growth we are experiencing and this move represents our commitment to building upon the successes our team has accomplished."
Final property selection will be completed within the next 45 days, with several weeks planned for gradual relocation. Completed facilities are expected to be fully operational by end of June.
BG Medical Technologies new location to support additional staff and planned capacity growth for laboratory services, media production, and customer support.
Mar 6, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, March 6, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) today announces the relocation to new corporate headquarters for accommodating its rapid growth and future expansion plans. These new facilities will provide increased capacity for medical marijuana laboratory testing, developing natural medicine solutions, media production, content creation, sales, and leadership functions across the company.
The newly designed laboratory is configured to work in tandem with BudGenius software upgrades aimed at significantly increasing labor efficiency across a network of integrated hardware. The new laboratory will also support added technologies for increased data collection. Dedicated media suites for educational video production are being established, along with an HD post-production facility for onsite video and audio editing. An expanded sales area has been selected to house regional trainings, and also to support call center growth through 2015.
"This new and creative space greatly increases our capabilities and aligns us with our ongoing growth. We expected this to build upon team synergies while providing our staff the resources to rapidly develop new technologies for medical marijuana and natural medicines," said Angel Stanz, Chief Executive Officer for BG Medical Technologies. "Our team is excited about the growth we are experiencing and this move represents our commitment to building upon the successes our team has accomplished."
Final property selection will be completed within the next 45 days, with several weeks planned for gradual relocation. Completed facilities are expected to be fully operational by end of June.
BG Medical Technologies Leads the Medical Marijuana Industry in Providing Transparency to Investors
Cannabis Research Firm and Medical Marijuana Testing Laboratory Announces Upgrades to Comprehensive Investor Relations Website
Mar 8, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, March 8, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) announces newly launched investor relations components for its company website at http://www.BgMedTech.com, reflecting their ongoing efforts to provide up-to-date information for medical marijuana investors and shareholders.
These upgrades provide a comprehensive overview of BG Medical Technologies from an investment advisory perspective, including recent news releases, corporate governance, regulatory filings, stock information, charts, quotes, and additional shareholder resources.
Angel Stanz, Chief Executive Officer of BG Medical Technologies stated, "We consider shareholder communications to be mission critical in our ongoing expansion. To reflect this commitment, we required an industry leader in IR presentation to provide our investors with timely, easily accessible information about our stock profile and business strategies. Equisolve's services provide us the best components to convey our story and exhibit our value proposition as we hone our strategy within the medical cannabis market."
"We are proud to add BG Medical Technologies to our client roster. Their focus on increased transparency, shareholder communication, and compliance speaks highly about the Company and we are happy that we were selected to fulfill such an important role," shared Tom Runzo, CEO of Equisolve.
BG Medical Technologies invites investors to be the first to receive information as it hits the newswire. Sign up to the news alert system today at http://www.BgMedTech.com/email-alert.
About BG Medical Technologies
Cannabis Research Firm and Medical Marijuana Testing Laboratory Announces Upgrades to Comprehensive Investor Relations Website
Mar 8, 2012 8:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, March 8, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC:RIGH) announces newly launched investor relations components for its company website at http://www.BgMedTech.com, reflecting their ongoing efforts to provide up-to-date information for medical marijuana investors and shareholders.
These upgrades provide a comprehensive overview of BG Medical Technologies from an investment advisory perspective, including recent news releases, corporate governance, regulatory filings, stock information, charts, quotes, and additional shareholder resources.
Angel Stanz, Chief Executive Officer of BG Medical Technologies stated, "We consider shareholder communications to be mission critical in our ongoing expansion. To reflect this commitment, we required an industry leader in IR presentation to provide our investors with timely, easily accessible information about our stock profile and business strategies. Equisolve's services provide us the best components to convey our story and exhibit our value proposition as we hone our strategy within the medical cannabis market."
"We are proud to add BG Medical Technologies to our client roster. Their focus on increased transparency, shareholder communication, and compliance speaks highly about the Company and we are happy that we were selected to fulfill such an important role," shared Tom Runzo, CEO of Equisolve.
BG Medical Technologies invites investors to be the first to receive information as it hits the newswire. Sign up to the news alert system today at http://www.BgMedTech.com/email-alert.
About BG Medical Technologies
Medical Marijuana Laboratory BudGenius Announces Free Online Medication Menu for Dispensaries
BudGenius' new "MenuGenius" application educates patients and reduces operational costs for medical marijuana caregivers
Mar 12, 2012 7:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, March 12, 2012 /PRNewswire/ -- BudGenius.com, an online medical marijuana laboratory system developed by BG Medical Technologies, Inc. (OTC:RIGH), announces "MenuGenius", a new online tool available to all cannabis caregivers. This application is offered to all cannabis professionals that signup for a free account on the BudGenius.com system. The online medicine menu displays statistics for both tested and untested variants of marijuana medicine, and is deployable to nearly any website at no additional charge. Medical marijuana directory websites can also take advantage of the tool, as it has been developed to integrate as an add-on module into several popular content management systems, offering native search capabilities for listed strains. Directory websites can also increase their revenue through an affiliate business model for medical cannabis testing, which comes integrated with the MenuGenius software.
BudGenius expects MenuGenius to largely replace its previously developed "badges" program, a system of deployable strain graphics for tested cannabis strains responsible for 20% of overall BudGenius.com site traffic. By introducing MenuGenius to all dispensaries nationwide this is expected to increase overall web traffic by 250% within six months, furthering brand awareness, and forming new relationships for future product releases. Ongoing increases in web traffic are planned to set a substantial foundation for BudGenius' advertising network, slated for release later this year.
Dispensaries will find the tool an appealing module to attract new patients, service current patients, and lower website development costs. Delivery services will also find the tool useful by connecting patients with their immediately available inventory. Caregivers are encouraged to deploy the menu nearly anywhere online including websites, forums, directories, and even email newsletters, all of which can be updated simultaneously in real-time.
"We are thrilled to be introducing the first easy-to-read online menu that displays important statistics while also showcasing the beauty of each cannabis strain," explains CEO, Angel Stanz. "We expect MenuGenius will encourage additional testing by medically conscious caregivers, while also supporting the cannabis industry through open information sharing."
A demonstration of MenuGenius is available at:
http://www.BudGenius.com/menu-genius.html" target="_blank" rel="nofollow ugc noopener">http://www.BudGenius.com/menu-genius.html
BudGenius launched an exclusive version of the menu earlier this year with strategic partner GreenbookPages.com , and celebrated with a widely distributed Los Angeles area billboard campaign. Caregivers immediately seeking a directory service that has integrated MenuGenius are invited to contact Greenbook Pages for their services.
MenuGenius will be made available on April 2nd for cannabis caregivers nationwide. Caregivers interested in participating immediately are encouraged to signup at http://www.BudGenius.com/signup.html" target="_blank" rel="nofollow ugc noopener">http://www.BudGenius.com/signup.html for a beta trial account.
About BudGenius.com
BudGenius.com is a social networking website, and leading provider of medical marijuana testing services located in California. In addition to cannabis safety screenings, BudGenius provides a unique rating system to assist patients in selecting marijuana strains more likely to efficiently treat specific medical conditions.
http://www.BudGenius.com
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. http://www.BgMedTech.com
BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis.
BudGenius' new "MenuGenius" application educates patients and reduces operational costs for medical marijuana caregivers
Mar 12, 2012 7:00:00 AM
Close Ad
Email story | Discuss on ZenoBank | View more ads
LOS ANGELES, March 12, 2012 /PRNewswire/ -- BudGenius.com, an online medical marijuana laboratory system developed by BG Medical Technologies, Inc. (OTC:RIGH), announces "MenuGenius", a new online tool available to all cannabis caregivers. This application is offered to all cannabis professionals that signup for a free account on the BudGenius.com system. The online medicine menu displays statistics for both tested and untested variants of marijuana medicine, and is deployable to nearly any website at no additional charge. Medical marijuana directory websites can also take advantage of the tool, as it has been developed to integrate as an add-on module into several popular content management systems, offering native search capabilities for listed strains. Directory websites can also increase their revenue through an affiliate business model for medical cannabis testing, which comes integrated with the MenuGenius software.
BudGenius expects MenuGenius to largely replace its previously developed "badges" program, a system of deployable strain graphics for tested cannabis strains responsible for 20% of overall BudGenius.com site traffic. By introducing MenuGenius to all dispensaries nationwide this is expected to increase overall web traffic by 250% within six months, furthering brand awareness, and forming new relationships for future product releases. Ongoing increases in web traffic are planned to set a substantial foundation for BudGenius' advertising network, slated for release later this year.
Dispensaries will find the tool an appealing module to attract new patients, service current patients, and lower website development costs. Delivery services will also find the tool useful by connecting patients with their immediately available inventory. Caregivers are encouraged to deploy the menu nearly anywhere online including websites, forums, directories, and even email newsletters, all of which can be updated simultaneously in real-time.
"We are thrilled to be introducing the first easy-to-read online menu that displays important statistics while also showcasing the beauty of each cannabis strain," explains CEO, Angel Stanz. "We expect MenuGenius will encourage additional testing by medically conscious caregivers, while also supporting the cannabis industry through open information sharing."
A demonstration of MenuGenius is available at:
http://www.BudGenius.com/menu-genius.html" target="_blank" rel="nofollow ugc noopener">http://www.BudGenius.com/menu-genius.html
BudGenius launched an exclusive version of the menu earlier this year with strategic partner GreenbookPages.com , and celebrated with a widely distributed Los Angeles area billboard campaign. Caregivers immediately seeking a directory service that has integrated MenuGenius are invited to contact Greenbook Pages for their services.
MenuGenius will be made available on April 2nd for cannabis caregivers nationwide. Caregivers interested in participating immediately are encouraged to signup at http://www.BudGenius.com/signup.html" target="_blank" rel="nofollow ugc noopener">http://www.BudGenius.com/signup.html for a beta trial account.
About BudGenius.com
BudGenius.com is a social networking website, and leading provider of medical marijuana testing services located in California. In addition to cannabis safety screenings, BudGenius provides a unique rating system to assist patients in selecting marijuana strains more likely to efficiently treat specific medical conditions.
http://www.BudGenius.com
About BG Medical Technologies
BG Medical Technologies develops ancillary support services for medical cannabis patients and professionals, including its flagship medical marijuana research laboratory and website portal, BudGenius.com. BG Medical Technologies, Inc. currently trades under the symbol OTC:RIGH. Symbol and name change pending. http://www.BgMedTech.com
BG Medical Technologies and its companies do not sell, grow, harvest, cultivate, nor distribute medical cannabis.
Wird stark diskutiert über diese Aktie in USA.
http://investorshub.advfn.com/boards/read_msg.aspx?message_i…
Besteht hier eine Verbindung zu Medbox?
http://investorshub.advfn.com/boards/read_msg.aspx?message_i…
Besteht hier eine Verbindung zu Medbox?
ist ein thema wert....
dilution?extremes volumen
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 223 | ||
| 192 | ||
| 107 | ||
| 57 | ||
| 46 | ||
| 40 | ||
| 37 | ||
| 36 | ||
| 33 | ||
| 31 |
| Wertpapier | Beiträge | |
|---|---|---|
| 31 | ||
| 26 | ||
| 26 | ||
| 26 | ||
| 24 | ||
| 21 | ||
| 19 | ||
| 18 | ||
| 17 | ||
| 17 |
